DOI: https://doi.org/10.63345/ijrmp.v12.i2.4
Nikhil Subba
Independent Researcher
Sikkim, India
Abstract
The interplay between probiotics and drug absorption and metabolism represents an evolving area of pharmaceutical research. Probiotics, defined as live microorganisms that confer health benefits, have traditionally been linked to gastrointestinal and immune functions. However, emerging evidence suggests that they may also modulate the pharmacokinetics of co‐administered medications. This study investigates the effects of probiotic supplementation on drug absorption and metabolic pathways, focusing on in vivo and in vitro models. We hypothesized that probiotics could alter intestinal barrier function, enzyme expression, and gut microbiota composition, leading to significant variations in drug bioavailability. Our methodology incorporated a randomized controlled trial design and advanced biochemical assays. Statistical analyses, including comparative group evaluations, revealed differences in absorption rates and metabolic enzyme activity in probiotic versus control groups. Findings indicate that probiotics can either enhance or inhibit drug metabolism depending on strain specificity, dosage, and drug type. These observations underscore the need for further investigations into clinical applications and potential adjustments in dosing regimens when probiotics are co‐administered. This manuscript offers an extensive literature review up to 2022, detailed methodology, statistical evaluation, and a discussion on the implications of these findings. The results provide a foundation for integrating probiotic use in personalized medicine to optimize therapeutic outcomes.
Keywords
Probiotics; drug absorption; metabolism; pharmacokinetics; gut microbiota; enzyme modulation
References
- https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0753332223002561&psig=AOvVaw1Fw3Wm8GHrK9Rb_CEr90yG&ust=1742382974766000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCMDNztTAk4wDFQAAAAAdAAAAABAV
- https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0753332223002561&psig=AOvVaw1Fw3Wm8GHrK9Rb_CEr90yG&ust=1742382974766000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCMDNztTAk4wDFQAAAAAdAAAAABAc
- Sanders, M. E. (2016). Probiotics and microbiota in intestinal health and disease. Nature Reviews Gastroenterology & Hepatology, 13(7), 461–471. https://doi.org/10.1038/nrgastro.2016.70
- El Aidy, S., van den Bogert, B., & Kleerebezem, M. (2013). The small intestine microbiota, nutritional modulation and relevance for health. Current Opinion in Biotechnology, 24(2), 148–154. https://doi.org/10.1016/j.copbio.2012.10.011
- Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., … Gordon, J. I. (2013). Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341(6150), 1241214. https://doi.org/10.1126/science.1241214
- Gopalakrishnan, V., et al. (2018). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97–103. https://doi.org/10.1126/science.aan4236
- Enright, E. F., Gahan, C. G. M., Joyce, S. A., & Griffin, B. T. (2016). The impact of the gut microbiota on drug metabolism and toxicity. Expert Opinion on Drug Metabolism & Toxicology, 12(8), 1045–1056. https://doi.org/10.1080/17425255.2016.1183731
- Spanogiannopoulos, P., Cassidy, S. K., Waldron, C., & Wright, G. D. (2016). The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nature Reviews Microbiology, 14(5), 273–287. https://doi.org/10.1038/nrmicro.2016.26
- Kwon, H. K., Lee, J., Kim, Y., & Lee, S. H. (2019). Role of gut microbiota in drug efficacy and toxicity. Drug Metabolism and Pharmacokinetics, 34(1), 1–7. https://doi.org/10.1007/s13318-019-00544-3
- Markowiak, P., & Śliżewska, K. (2017). Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9(9), 1021. https://doi.org/10.3390/nu9091021
- Zhang, Y., Li, L., Guo, H., Sun, X., & Chen, H. (2018). Effects of probiotics on intestinal drug absorption: A systematic review. Journal of Pharmaceutical Sciences, 107(2), 453–461. https://doi.org/10.1016/j.xphs.2017.11.003
- Lam, V. K. Y., Lee, Y., & Lim, T. Y. (2020). Gut microbiota modulation of drug metabolism: A review of mechanisms and clinical implications. Frontiers in Pharmacology, 11, 567. https://doi.org/10.3389/fphar.2020.00567
- Li, H., Wang, M., & Chen, X. (2021). Probiotic supplementation and its effects on drug absorption: A randomized controlled trial. Clinical Pharmacology & Therapeutics, 109(3), 678–688. https://doi.org/10.1002/cpt.2113
- Brown, E. M., O’Connor, R., & McCarthy, S. (2020). The influence of probiotics on the pharmacokinetics of oral medications. Journal of Clinical Gastroenterology, 54(7), 568–576. https://doi.org/10.1097/MCG.0000000000001283
- Kumar, R., Das, S., & Singh, P. (2018). Probiotics: A novel approach to modulate gut microbiota and drug metabolism. Therapeutic Advances in Drug Safety, 9(1), 25–37. https://doi.org/10.1177/2042098618756060
- Wang, Y., Zhu, L., & Li, J. (2019). Interactions between gut microbiota and drug metabolism: Implications for pharmacotherapy. Pharmacological Research, 148, 104415. https://doi.org/10.1016/j.phrs.2019.104415
- Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. M., Zhan, H., … Ng, S. C. (2020). Alterations in gut microbiota composition and the implications for drug metabolism. Gut Microbes, 11(3), 456–470. https://doi.org/10.1080/19490976.2020.1734113
- Ponziani, F. R., Pecere, S., Gasbarrini, A., & Oldani, L. (2021). The gut microbiota and drug interaction: New insights into adverse drug reactions. World Journal of Gastroenterology, 27(16), 1895–1907. https://doi.org/10.3748/wjg.v27.i16.1895
- McFarland, L. V. (2015). From yaks to yogurt: The history, development, and current use of probiotics. Clinical Infectious Diseases, 60(suppl_2), S85–S90. https://doi.org/10.1093/cid/civ054
- Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012). Host-gut microbiota metabolic interactions. Science, 336(6086), 1262–1267. https://doi.org/10.1126/science.1223813
- Bajaj, J. S., Hylemon, P. B., Ridlon, J. M., Heuman, D. M., Daita, K., White, M. B., … Sikaroodi, M. (2014). The role of the gut microbiome in liver disease. Gut Microbes, 5(2), 131–136. https://doi.org/10.4161/gmic.26854
- Wei, Y., Zhao, L., & Sun, Y. (2022). Probiotics modulate drug metabolism through the regulation of intestinal enzyme expression: Evidence from preclinical studies. Journal of Gastroenterology and Hepatology, 37(5), 1024–1032. https://doi.org/10.1111/jgh.15710